
- BioPharm International-08-01-2016
- Volume 29
- Issue 8
Syringe Pump for Continuous Flow Chemical Processing
The Titan Syringe Pump from Syrris is a continuous flow chemical processing module suitable for lab-, pilot-, and production-scale applications.
The Titan Syringe Pump from Syrris is a continuous flow chemical processing module suitable for lab-, pilot-, and production-scale applications. The pump is chemically-resistant and combines drive motors, valve design, and software control to deliver flow rates from 1 to 250 mL/min.
The pump, designed for reliable scale-up, operates at pressures up to 20 bar and viscosities up to 1000 cP, delivering precisely controlled flow rates for extended periods. The pump contains removable cassettes that allow straightforward serving of syringes and enable seals to be rapidly changed with minimal tools required. A built-in backwash feature prolongs seal lifetime and maintains the cleanliness of pistons and cylinders, which also helps to prevent degradation of air-sensitive chemicals and protect users. The Titan Syringe Pump can be controlled manually via the Titan Remote Display touch screen or fully automated through PC software, and it is compatible with a wide range of chemical reaction systems.
Articles in this issue
about 9 years ago
Generating a Fully Processed Antibodyabout 9 years ago
Perfusion in the 21st Centuryabout 9 years ago
Protein Impurities Pose Challengesabout 9 years ago
All Buzz, No Biteabout 9 years ago
Analysis of Glycosylation in Biosimilarsabout 9 years ago
Quality Manufacturing Key to Stemming Drug Shortagesabout 9 years ago
Downstream Processing Continues to Worry CMOsabout 9 years ago
One Strategy for Updating an Aging Facilityabout 9 years ago
Integrating Single-Use Systems in Biopharma Manufacturingabout 9 years ago
The Flexibility of Small-Scale Single-Use Bioreactor SolutionsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.